Cargando…
Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cells
Purpose: The tumor homing characteristics of mesenchymal stem cells (MSCs) make them attractive vehicles for the tumor-specific delivery of therapeutic agents, such as the sodium iodide symporter (NIS). NIS is a theranostic protein that allows non-invasive monitoring of the in vivo biodistribution o...
Autores principales: | Tutter, Mariella, Schug, Christina, Schmohl, Kathrin A., Urnauer, Sarah, Schwenk, Nathalie, Petrini, Matteo, Lokerse, Wouter J. M., Zach, Christian, Ziegler, Sibylle, Bartenstein, Peter, Weber, Wolfgang A., Wagner, Ernst, Lindner, Lars H., Nelson, Peter J., Spitzweg, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150485/ https://www.ncbi.nlm.nih.gov/pubmed/32292510 http://dx.doi.org/10.7150/thno.41489 |
Ejemplares similares
-
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
por: Kitzberger, Carolin, et al.
Publicado: (2022) -
EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases
por: Urnauer, Sarah, et al.
Publicado: (2017) -
Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene
por: Schmohl, Kathrin A., et al.
Publicado: (2017) -
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes
por: Spellerberg, Rebekka, et al.
Publicado: (2021) -
Taking Advantage of the TGFB1 Biology in Differentiated Thyroid Cancer to Stimulate Sodium Iodide Symporter (NIS)-Mediated Iodide Uptake in Engineered Mesenchymal Stem Cells
por: Han, Yang, et al.
Publicado: (2021)